Cited by 890Bone Metabolism and DiseasesBone health and treatmentsBone health and osteoporosis research

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

Open access

Plotkin, Lilian I., Weinstein, Robert S., Parfitt, A. Michael, Roberson, Paula K., Manolagas, Stavros C., Bellido, Teresita·1999·Journal of Clinical Investigation

DOI 10.1172/jci6800PMC PMC409837

Open this paper in CoChat — free account Open PDF

Abstract

Glucocorticoid-induced osteoporosis may be due, in part, to increased apoptosis of osteocytes and osteoblasts, and bisphosphonates (BPs) are effective in the management of this condition. We have tested the hypothesis that BPs suppress apoptosis in these cell types. Etidronate, alendronate, pamidronate, olpadronate, or amino-olpadronate (IG9402, a bisphosphonate that lacks antiresorptive activity) at 10(-9) to 10(-6) M prevented apoptosis of murine osteocytic MLO-Y4 cells, whether it was induced by etoposide, TNF-alpha, or the synthetic glucocorticoid dexamethasone. BPs also inhibited apoptosis of primary murine osteoblastic cells isolated from calvaria. Similar antiapoptotic effects on MLO-Y4 and osteoblastic cells were seen with nanomolar concentrations of the peptide hormone calcitonin. The antiapoptotic effect of BPs and calcitonin was associated with a rapid increase in the phosphorylated fraction of extracellular signal regulated kinases (ERKs) and was blocked by specific inhibitors of ERK activation. Consistent with these in vitro results, alendronate abolished the increased prevalence of apoptosis in vertebral cancellous bone osteocytes and osteoblasts that follows prednisolone administration to mice. These results suggest that the therapeutic efficacy of BPs or calcitonin in diseases such as glucocorticoid-induced osteoporosis may be due, in part, to their ability to prevent osteocyte and osteoblast apoptosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci6800

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Caspases: Enemies Within
Thornberry, N. A., & Lazebnik, Y. A. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,857
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,273
PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,374
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Dyk, D. E. V., Pitts, W. J., Earl, R. A., Hobbs, F. W., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,016
The Fire of Life: An Introduction to Animal Energetics
Kleiber, M. (1975) · Medical Entomology and Zoology · Cited by 2,529
A short amino acid sequence able to specify nuclear location
Kalderon, D., Roberts, B., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,511
Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 12×
“The TUNEL reaction was performed according to the manufacturer’s instructions, using 0.15% CuSO4 for color enhancement.”
BackgroundMethodResultInfluentialSelf-citation
Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras
Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068

Flagged first, then by citations

Show all 62 references

Research works printed but not linked: 8

Cummings, 1996, J Bone Miner Res, 11(Suppl.), S102
Marotti, 1990, Ital J Miner Electrol Metab, 4, 93
Dennison, 1999, Osteoporos Int, 9, S16
Weinstein, 1998, Bone, 23(Suppl), S461
Falcini, 1996, Calcif Tissue Int, 58, 166
Grignani, 1998, Cancer Res, 58, 14
Giuliani, 1995, J Bone Miner Res, 10(Suppl), S171
Marotti, 1996, Ital J Anat Embryol, 101, 25

Sorted by citations

Items 301–400 of 888

Bone turnover markers and sex hormones in men with idiopathic osteoporosis
Pietschmann, P., Kudlacek, S., Grisar, J., Spitzauer, S., Woloszczuk, W., Willvonseder, R., & Peterlik, M. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00836.x · Cited by 62
LIS1 Regulates Osteoclast Formation and Function through Its Interactions with Dynein/Dynactin and Plekhm1
Ye, S., Fowler, T. W., Pavlos, N. J., Ng, P. Y., Liang, K., Feng, Y., Zheng, M., Kurten, R. C., Manolagas, S. C., & Zhao, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027285 · Cited by 49
Self-citation
Bcl2 Deficiency Activates FoxO through Akt Inactivation and Accelerates Osteoblast Differentiation
Moriishi, T., Kawai, Y., Komori, H., Rokutanda, S., Eguchi, Y., Tsujimoto, Y., Asahina, I., & Komori, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086629 · Cited by 47
Glucocorticoid-induced osteoporosis: pathophysiological data and recent treatments
Lafage‐Proust, M., Boudignon, B. M., & Thomas, T. (2003) · Joint Bone Spine · doi:10.1016/s1297-319x(03)00016-2 · Cited by 47
Lexical Bundles in Native and Non-native Scientific Writing: Applying a corpus-based study to language teaching
Salazar, D. (2014) · Cited by 47
Inhibition of the Progesterone Nuclear Receptor during the Bone Linear Growth Phase Increases Peak Bone Mass in Female Mice
Yao, W., Dai, W., Shahnazari, M., Pham, A., Chen, Z., Chen, H., Guan, M., & Lane, N. E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011410 · Cited by 47
The Role of Muscle Loading on Bone (Re)modeling at the Developing Enthesis
Tatara, A. M., Lipner, J., Das, R., Kim, H. M., Patel, N., Ntouvali, E., Silva, M. J., & Thomopoulos, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097375 · Cited by 48
Long-term effects of neridronate on human osteoblastic cell cultures
Frediani, B., Spreafico, A., Capperucci, C., Chellini, F., Gambera, D., Ferrata, P., Baldi, F., Falsetti, P., Santucci, A., Bocchi, L., et al. (2004) · Bone · doi:10.1016/j.bone.2004.06.001 · Cited by 47
In vitro effects of combination chemotherapy on osteoblasts: implications for osteopenia in childhood malignancy
Davies, J. H., Evans, B. A. J., Jenney, M. E. M., & Gregory, J. W. (2002) · Bone · doi:10.1016/s8756-3282(02)00822-0 · Cited by 46
Bisphosphonates: Environmental protection for the joint?
Goldring, S. R., & Gravallese, E. M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20383 · Cited by 45
Bisphosphonates: mechanisms of action
Fleisch, H. A. (2001) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.11.9.1371 · Cited by 47
Clinical and Basic Aspects of Glucocorticoid Action in Bone
Kream, B. E., Graves, L., & Lukert, B. P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00061-6 · Cited by 47
TREATMENT OF ESTABLISHED BONE LOSS AFTER RENAL TRANSPLANTATION WITH ETIDRONATE1
Arlen, D. J., Lambert, K., Ioannidis, G., & Adachi, J. D. (2001) · Transplantation · doi:10.1097/00007890-200103150-00017 · Cited by 45
Simulated resistance training, but not alendronate, increases cortical bone formation and suppresses sclerostin during disuse
Macias, B. R., Swift, J. M., Nilsson, M. I., Hogan, H. A., Bouse, S. D., & Bloomfield, S. A. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00978.2011 · Cited by 47
Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner
Pellegrini, G., Morales, C. C., Wallace, T. C., Plotkin, L. I., & Bellido, T. (2016) · Nutrients · doi:10.3390/nu8070423 · Cited by 45
Self-citation
Phenomenon of osteocyte lacunar mineralization: indicator of former osteocyte death and a novel marker of impaired bone quality?
Milovanovic, P. D., & Busse, B. (2020) · Endocrine Connections · doi:10.1530/ec-19-0531 · Cited by 43
Abnormal bone turnover in long‐standing Crohn’s disease in remission
Schoon, E. J., Geerling, B. G., van Dooren, I. M. A., Schurgers, L. J., Vermeer, C., Brummer, R. J., & Stockbrügger, R. W. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00997.x · Cited by 45
Medication-related osteonecrosis of the jaw: An update
Bansal, H. (2022) · National Journal of Maxillofacial Surgery · doi:10.4103/njms.njms_236_20 · Cited by 45
Osteoprotegerin Prevents Glucocorticoid-Induced Osteocyte Apoptosis in Mice
Weinstein, R. S., O’Brien, C. A., Almeida, M., Zhao, H., Roberson, P. K., Jilka, R. L., & Manolagas, S. C. (2011) · Endocrinology · doi:10.1210/en.2011-0170 · Cited by 44
Self-citation
Feeding Blueberry Diets to Young Rats Dose-Dependently Inhibits Bone Resorption through Suppression of RANKL in Stromal Cells
Zhang, J., Lazarenko, O. P., Kang, J., Blackburn, M. L., Ronis, M. J. J., Badger, T. M., & Chen, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070438 · Cited by 44
Mutual augmentation of the induction of the histamine-forming enzyme, histidine decarboxylase, between alendronate and immuno-stimulants (IL-1, TNF, and LPS), and its prevention by clodronate
Deng, X., Yu, Z., Funayama, H., Shoji, N., Sasano, T., Iwakura, Y., Sugawara, S., & Endo, Y. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.09.005 · Cited by 44
Effect of 17ß-estradiol or alendronate on the bone densitometry, bone histomorphometry and bone metabolism of ovariectomized rats
da Paz, L. H. B. C., de Falco, V., Teng, N. C., dos Reis, L. M., Pereira, R. M. R., & Jorgetti, V. (2001) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2001000800007 · Cited by 43
Akt drives buffalo casein-derived novel peptide-mediated osteoblast differentiation
Reddi, S., Kumar, N., Vij, R., Mada, S. B., Kapila, S., & Kapila, R. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.08.003 · Cited by 43
Cadmium modulates hematopoietic stem and progenitor cells and skews toward myelopoiesis in mice
Zhang, Y., Yu, X., Sun, S., Li, Q., Xie, Y., Li, Q., Zhao, Y., Pei, J., Zhang, W., Xue, P., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.10.016 · Cited by 44
Treatment options for glucocorticoid-induced osteoporosis
Chiodini, I., Merlotti, D., Falchetti, A., & Gennari, L. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1721467 · Cited by 44
Glucocorticoid-Induced Osteoporosis
Lukert, B. P. (1992) · Southern Medical Journal · doi:10.1097/00007611-199208001-00009 · Cited by 42
RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice
Pin, F., Jones, A. J., Huot, J. R., Narasimhan, A., Zimmers, T. A., Bonewald, L. F., & Bonetto, A. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4480 · Cited by 42
Osteogenic growth peptide effects on primary human osteoblast cultures: Potential relevance for the treatment of glucocorticoid‐induced osteoporosis
Spreafico, A., Frediani, B., Capperucci, C., Leonini, A., Gambera, D., Ferrata, P., Rosini, S., Stefano, A. D., Galeazzi, M., & Marcolongo, R. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20836 · Cited by 41
Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia
Leblicq, C., Laverdière, C., Décarie, J., Delisle, J., Isler, M., Moghrabi, A., Chabot, G., & Alos, N. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24313 · Cited by 42
Apoptosis: an introduction for the endodontist
Satchell, P. G., Gutmann, J. L., & Witherspoon, D. E. (2003) · International Endodontic Journal · doi:10.1046/j.1365-2591.2003.00657.x · Cited by 42
Effects of Vitamin K2 and Risedronate on Bone Formation and Resorption, Osteocyte Lacunar System, and Porosity in the Cortical Bone of Glucocorticoid-Treated Rats
Iwamoto, J., Matsumoto, H., Takeda, T., Satō, Y., Liu, X., & Yeh, J. K. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9146-1 · Cited by 44
The molecular etiology and treatment of glucocorticoid-induced osteoporosis
Peng, C.-H., Lin, W.-Y., Yeh, K., Chen, I., Wu, W., & Lin, M. (2021) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_233_20 · Cited by 41
Enhancement of Periprosthetic Bone Quality with Topical Hydroxyapatite-Bisphosphonate Composite
Suratwala, S. J., Cho, S. K.-W., van Raalte, J. J., Park, S. H., Seo, S. W., Chang, S.-S., Gardner, T. R., & Lee, F. Y. (2008) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.g.00409 · Cited by 41
Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures
Itoh, F., Aoyagi, S., Furihata-Komatsu, H., Aoki, M., Kusama, H., Kojima, M., & Kogo, H. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.011 · Cited by 41
Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue
Reinholz, G. G., Getz, B. J., Sanders, E. S., Karpeisky, M. Y., Padyukova, N. S., Mikhailov, S. N., Ingle, J. N., & Spelsberg, T. C. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1014418017382 · Cited by 41
Calcitonin: The Other Thyroid Hormone
Inzerillo, A. M., Zaidi, M., & Huang, C. L.-H. (2002) · Thyroid · doi:10.1089/105072502760339352 · Cited by 45
Nothing but skin and bone
Ross, F. P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28605 · Cited by 43
Bisphosphonate Binding Affinity Affects Drug Distribution in Both Intracortical and Trabecular Bone of Rabbits
Turek, J. J., Ebetino, F. H., Lundy, M. W., Sun, S., Kashemirov, B. A., McKenna, C. E., Gallant, M. A., Plotkin, L. I., Bellido, T., Duan, X., et al. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9570-0 · Cited by 40
Self-citation
Effects of estrogen deficiency and bisphosphonate therapy on osteocyte viability and microdamage accumulation in an ovine model of osteoporosis
Brennan, O., Kennedy, O. D., Lee, T. C., Rackard, S. M., & O’Brien, F. J. (2010) · Journal of Orthopaedic Research® · doi:10.1002/jor.21229 · Cited by 40
Different Susceptibilities of Osteoclasts and Osteoblasts to Glucocorticoid-Induced Oxidative Stress and Mitochondrial Alterations
Chen, Y., Peng, S.-Y., Cheng, M.-T., Hsu, Y.-P., Huang, Z.-X., Cheng, W. T.-K., & Wu, S. (2019) · The Chinese Journal of Physiology · doi:10.4103/cjp.cjp_7_19 · Cited by 39
Osteoporosis prevention and therapy: preserving and building strength through bone quality
Kleerekoper, M. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0187-x · Cited by 40
RANKL Inhibition Improves Bone Properties in a Mouse Model of Osteogenesis Imperfecta
Bargman, R., Huang, A. H., Boskey, A. L., Raggio, C., & Pleshko, N. L. (2010) · Connective Tissue Research · doi:10.3109/03008200903108472 · Cited by 40
Alendronate as an Effective Treatment for Bone Loss and Vascular Calcification in Kidney Transplant Recipients
Okamoto, M., Yamanaka, S., Yoshimoto, W., & Shigematsu, T. (2014) · Journal of Transplantation · doi:10.1155/2014/269613 · Cited by 39
Role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw
Kim, J., Landayan, M. E. A., Lee, J. Y., Tatad, J. C. I., Kim, S., Kim, M.-R., & Cha, I. (2016) · Clinical Oral Investigations · doi:10.1007/s00784-016-1718-2 · Cited by 39
Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis
Wang, Y.-K., Qin, S., Ma, T., Song, W., Jiang, R., Guo, J., Li, K., & Zhang, Y. (2017) · Medicine · doi:10.1097/md.0000000000006970 · Cited by 40
Lexical bundles in scientific English: A corpus-based study of native and non-native writing
Salazar, L., & Joy, D. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 39
PTH receptor signalling, osteocytes and bone disease induced by diabetes mellitus
Marino, S., & Bellido, T. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01014-7 · Cited by 42
Self-citation
Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation
Coe, L. M., Tekalur, S. A., Shu, Y., Baumann, M. J., & McCabe, L. R. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24929 · Cited by 38
Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment
Popp, A. W., Isenegger, J., Buergi, E. M., Buergi, U., & Lippuner, K. (2006) · European Spine Journal · doi:10.1007/s00586-005-0056-x · Cited by 39
Histomorphometric Evaluation of the Effects of Zoledronic Acid on Mandibular Distraction Osteogenesis in Rabbits
Pampu, A. A., Dolanmaz, D., Tüz, H. H., Avunduk, M. C., & Kisnisci, R. S. (2008) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2007.12.004 · Cited by 38
The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids
Balooch, G., Yao, W., Ager, J. W., Balooch, M., Nalla, R. K., Porter, A. E., Ritchie, R. O., & Lane, N. E. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22976 · Cited by 37
A new bisphosphonate, YM529 induces apoptosis in HL60 cells by decreasing phosphorylation of single survival signal ERK
Nishida, S., Fujii, Y., Yoshioka, S., Kikuichi, S., Tsubaki, M., & Irimajiri, K. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00664-7 · Cited by 37
Ibandronate promotes osteogenic differentiation of periodontal ligament stem cells by regulating the expression of microRNAs
Zhou, Q., Zhao, Z., Cheng, J.-T., Zhang, B., Xu, J. H., Huang, F., Rui-ni, Z., & Chen, Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.079 · Cited by 37
Activation of p38 MAPK-regulated Bcl-xL signaling increases survival against zoledronic acid-induced apoptosis in osteoclast precursors
Tai, T., Su, F., Chen, C., Jou, I., & Lin, C. (2014) · Bone · doi:10.1016/j.bone.2014.07.003 · Cited by 38
A supplement‐free osteoclast–osteoblast co‐culture for pre‐clinical application
Schulze, S., Wehrum, D., Dieter, P., & Hempel, U. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26076 · Cited by 36
Bisphosphonates and Cancer: What Opportunities from Nanotechnology?
Rosa, G. D., Misso, G., Salzano, G., & Caraglia, M. (2013) · Journal of Drug Delivery · doi:10.1155/2013/637976 · Cited by 39
Bisphosphonates activate nucleotide receptors signaling and induce the expression of Hsp90 in osteoblast-like cell lines
Romanello, M., Bivi, N., Pines, A., Deganuto, M., Quadrifoglio, F., Moro, L., & Tell, G. (2006) · Bone · doi:10.1016/j.bone.2006.03.011 · Cited by 37
Myeloma and bone disease: "the dangerous tango".
Epstein, J., & Walker, R. C. (2006) · PubMed · Cited by 37
Apoptosis in Bone Cells
Boyce, B. F., Hughes, D. E., Wright, K. R., Xing, L., & Dai, A. (1998) · Springer eBooks · doi:10.1007/978-3-662-09007-7_3 · Cited by 37
Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition
Chaplet, M., Detry, C., Deroanne, C., Fisher, L. W., Castronovo, V., & Bellahcène, A. (2004) · Biochemical Journal · doi:10.1042/bj20040380 · Cited by 37
Clinical role of bisphosphonate therapy
Fogelman, I., & Hampson (2012) · International Journal of Women s Health · doi:10.2147/ijwh.s24783 · Cited by 37
FoxO1 expression in osteoblasts modulates bone formation through resistance to oxidative stress in mice
Zhang, Y., Xiong, Y., Zhou, J., Xin, N., Zhu, Z., & Wu, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.055 · Cited by 37
Treatment of Renal Transplant Recipients With Low Bone Mineral Density: A Randomized Prospective Trial of Alendronate, Alfacalcidol, and Alendronate Combined With Alfacalcidol
Trabulus, S., Altıparmak, M. R., Apaydın, S., Serdengeçtı, K., & Sarıyar, M. (2008) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.12.001 · Cited by 36
Stimulation of bone formation by zoledronic acid in particle-induced osteolysis
Wedemeyer, C., von Knoch, F., Pingsmann, A., Hilken, G., Sprecher, C. M., Saxler, G., Henschke, F., Löer, F., & von Knoch, M. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.09.026 · Cited by 36
Anabolic effects of bisphosphonates on peri-implant bone stock
von Knoch, F., Eckhardt, C. M., Alabre, C. I., Schneider, E. H., Rubash, H. E., & Shanbhag, A. S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.04.024 · Cited by 36
Effect of pamidronate on new vertebral fractures and bone mineral density in patients with malignant lymphoma receiving chemotherapy
Kim, S. H., Lim, S. K., & Hahn, J. S. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.12.019 · Cited by 36
Glucocorticoid-induced Osteoporosis and Its Treatment
Pennisi, P., Trombetti, A., & Rizzoli, R. (2006) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000200238.29931.1f · Cited by 36
Long Non-Coding RNA MALAT1 Protects Human Osteoblasts from Dexamethasone-Induced Injury via Activation of PPM1E-AMPK Signaling
Fan, J., Zhang, Y., Liu, W., Zhu, X., Xu, D., Zhao, J., & Cui, Z. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495159 · Cited by 35
Quantitative Determination of Alendronate in Human Urine
Gupta, V. K., Jain, R., Sharma, S., Agarwal, S., & Dwivedi, A. (2012) · International Journal of Electrochemical Science · doi:10.1016/s1452-3981(23)13360-8 · Cited by 36
The Impact of Bone Turnover and Bone-Active Agents on Bone Quality: Focus on the Hip
Dempster, D. W. (2002) · Osteoporosis International · doi:10.1007/s001980200038 · Cited by 35
Protein isoprenylation regulates osteogenic differentiation of mesenchymal stem cells: effect of alendronate, and farnesyl and geranylgeranyl transferase inhibitors
Duque, G., Vidal, C., & Rivas, J. D. L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01111.x · Cited by 34
The effect of simvastatin on polyethylene particle-induced osteolysis
von Knoch, F., Heckelei, A., Wedemeyer, C., Saxler, G., Hilken, G., Henschke, F., Löer, F., & von Knoch, M. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.09.043 · Cited by 34
Anabolic and antiresorptive actions of locally delivered bisphosphonates for bone repair
Qayoom, I., Raina, D. B., Širka, A., Tarasevičius, Š., Tägil, M., Kumar, A., & Lidgren, L. (2018) · Bone and Joint Research · doi:10.1302/2046-3758.710.bjr-2018-0015.r2 · Cited by 34
Apoptosis may determine the release of skeletal alkaline phosphatase activity from human osteoblast-line cells
Farley, J. R., & Stilt-Coffing, B. (2001) · Calcified Tissue International · doi:10.1007/bf02685002 · Cited by 34
Effect of Topical Alendronate Treatment on Fixation of Implants Inserted with Bone Compaction
Jakobsen, T., Kold, S., Bechtold, J. E., Elmengaard, B., & Søballé, K. (2006) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000191273.34786.40 · Cited by 34
Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in postmenopausal osteoporosis
Delmas, P. D. (2002) · Bone · doi:10.1016/s8756-3282(01)00667-6 · Cited by 33
Overexpression of BCLXL in Osteoblasts Inhibits Osteoblast Apoptosis and Increases Bone Volume and Strength
Moriishi, T., Fukuyama, R., Miyazaki, T., Furuichi, T., Ito, M., & Komori, T. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2808 · Cited by 33
Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss
Lindtner, R. A., Tiaden, A. N., Genelin, K., Ebner, H. L., Manzl, C., Klawitter, M., Sitte, I., von Rechenberg, B., Blauth, M., & Richards, P. J. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2494-3 · Cited by 34
Effects of alendronate for treatment of glucocorticoid-induced osteoporosis
Wang, Y.-K., Zhang, Y.-M., QIN, S.-Q., Wang, X., Ma, T., Guo, J.-B., Zhu, C., & Luo, Z.-J. (2018) · Medicine · doi:10.1097/md.0000000000012691 · Cited by 34
l-Carnitine protects against apoptosis of murine MC3T3-E1 osteoblastic cells
Xie, H., Tang, S., Li, H., Luo, X., Yuan, L., Wang, D., & Liao, E.-Y. (2007) · Amino Acids · doi:10.1007/s00726-007-0598-9 · Cited by 33
Postmenopausal osteoporosis. What have we learned since the introduction of bisphosphonates?
Chaiamnuay, S., & Saag, K. G. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9008-y · Cited by 32
Alendronate augments interleukin-1β release from macrophages infected with periodontal pathogenic bacteria through activation of caspase-1
Deng, X., Tamai, R., Endo, Y., & Kiyoura, Y. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.11.005 · Cited by 33
Postmenopausal osteoporosis and alendronate
Pérez-López, F. R. (2004) · Maturitas · doi:10.1016/j.maturitas.2003.12.006 · Cited by 33
Calcitonin and Prednisolone Display Antagonistic Actions on Bone and Have Synergistic Effects in Experimental Arthritis
Mancini, L., Paul-Clark, M. J., Rosignoli, G., Hannon, R., Martin, J. E., Macintyre, I., & Perretti, M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060830 · Cited by 32
Bisphosphonates for osteoporosis: from bench to clinic
Bellido, T. (2024) · Journal of Clinical Investigation · doi:10.1172/jci179942 · Cited by 32
Self-citation
Role of connexin 43 in the mechanism of action of alendronate: Dissociation of anti-apoptotic and proliferative signaling pathways
Lezcano, V., Bellido, T., Plotkin, L. I., Boland, R., & Morelli, S. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.12.022 · Cited by 33
Self-citation
High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro
Davis, H. M., Valdez, S., Gomez, L., Malicky, P., White, F. A., Subler, M. A., Windle, J. J., Bidwell, J. P., Bruzzaniti, A., & Plotkin, L. I. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28932 · Cited by 31
Self-citation
Bisphosphonates Targeting Ion Channels and Musculoskeletal Effects
Scala, R., Maqoud, F., Antonacci, M., Dibenedetto, J. R., Perrone, M. G., Scilimati, A., Castillo, K., Latorre, R., Camerino, D. C., Bendahhou, S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837534 · Cited by 33
The influence of alendronate on bone formation after autogenous free bone grafting in rats
Altundal, H., & Gürsoy, B. (2004) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2004.05.022 · Cited by 32
Bisphosphonates: Pharmacology and Clinical Approach to Their Use in Equine Osteoarticular Diseases
Soto, S., & Barbará, A. C. (2014) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2014.01.009 · Cited by 31
Is interaction between age-dependent decline in mechanical stimulation and osteocyte–estrogen receptor levels the culprit for postmenopausal-impaired bone formation?
Sapir‐Koren, R., & Livshits, G. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2208-2 · Cited by 33
Revisiting bone targeting potential of novel hydroxyapatite based surface modified PLGA nanoparticles of risedronate: Pharmacokinetic and biochemical assessment
Rawat, P., Ahmad, I., Thomas, S. C., Pandey, S., Vohora, D., Gupta, S., Ahmad, F. J., & Talegaonkar, S. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.049 · Cited by 35
Bisphosphonates in inflammatory rheumatic diseases
Peris, P., Monegal, A., & Guañabens, N. (2021) · Bone · doi:10.1016/j.bone.2021.115887 · Cited by 31
Protein phosphatases: Possible bisphosphonate binding sites mediating stimulation of osteoblast proliferation
Morelli, S. R., Bilbao, P., Katz, S., Lezcano, V., Ej, R., Boland, R., & Santillán, G. E. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.12.013 · Cited by 31
Healing of the bone with anti-fracture drugs
Brandi, M. L. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.801959 · Cited by 31
Prolonged, Symptomatic Hypocalcemia with Pamidronate Administration and Subclinical Hypoparathyroidism
Mishra, A., Wong, L. L., & Jonklaas, J. (2001) · Endocrine · doi:10.1385/endo:14:2:159 · Cited by 31
Protein tyrosine phosphatases in skeletal development and diseases
Yang, H., Wang, L., Shigley, C., & Yang, W. (2022) · Bone Research · doi:10.1038/s41413-021-00181-x · Cited by 32
Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma
Lee, J. M., Kim, J. E., Bae, S. H., & Hah, J. O. (2013) · Blood Research · doi:10.5045/br.2013.48.2.99 · Cited by 30
Effects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk–hydroxyapatite films
Hayden, R. S., Vollrath, M., & Kaplan, D. L. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.09.028 · Cited by 30
Optimum management of glucocorticoid-treated patients
Trikudanathan, S., & McMahon, G. T. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0791 · Cited by 29

Authors: Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T.
Affiliations: University of Arkansas for Medical Sciences (US)
Central Arkansas Veterans Healthcare System (US)
Corresponding author: Bellido, Teresita
ORCID: Plotkin, Lilian I.
Weinstein, Robert S.
Roberson, Paula K.
Manolagas, Stavros C.
Bellido, Teresita
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1999-11-15
Volume: 104
Issue: 10
Pages: 1363-1374
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci6800
PMC: PMC409837
OpenAlex: W2170680219
Cited by: 890
References: 62
Citations by year: 2026: 5 · 2025: 8 · 2024: 11 · 2023: 13 · 2022: 19 · 2021: 15 · 2020: 21 · 2019: 24 · 2018: 24 · 2017: 29 · 2016: 41 · 2015: 26 · 2014: 54 · 2013: 44 · 2012: 40
FWCI: 11.43
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ar043003-05)
National Institute on Aging (P01AG/AMS13918, P01AG013918)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR43003, R01AR046191)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Oncology › Bone health and treatments
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords: bisphosphonates, calcitonin, osteocyte apoptosis, osteoblast apoptosis, glucocorticoid-induced osteoporosis, alendronate, etidronate, pamidronate, extracellular signal-regulated kinase, ERK1/2 phosphorylation, dexamethasone, TNF-α, etoposide, prednisolone, MLO-Y4 cells, trabecular bone
MeSH terms: Pamidronate, Animals, Calcitonin, Cell Line, Cells, Cultured, Dexamethasone, Diphosphonates, Etoposide, Osteoblasts, Osteocytes, Prednisolone, Skull, Etidronic Acid, Tumor Necrosis Factor-alpha, Apoptosis, Alendronate, In Situ Nick-End Labeling, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks